# Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-tofacitinib-an-oral-janus-kinase-inhibitor-for-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | J. Wollenhaupt,Joel C. Silverfield,Eun Bong Lee,Jeffrey R. Curtis,Susan P. Wood,Koshika Soma,Chudy I. Nduaka,Birgitta Benda,David Gruben,Hiroyuki Nakamura,Yoshihiro Komuro,Samuel H. Zwillich,Lisy Wang,Richard J. Riese |
| Citations | 303 |
| DOI | 10.3899/jrheum.130683 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.jrheum.org/content/jrheum/41/5/837.full.pdf |
| OpenAlex ID | https://openalex.org/W2046744512 |
| PMID | 24692527 |
| Type | article |
| Year | 2014 |

## Paper authors

- [David Gruben](https://scholariq.org/researchers/david-gruben/)

## Paper journal

- [The Journal of Rheumatology](https://scholariq.org/journals/the-journal-of-rheumatology/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.